Summary & Overview
HCPCS G8581: No Antiplatelet Medication at Discharge
HCPCS Level II code G8581 denotes the documentation that a patient was discharged without an antiplatelet medication. This administrative measure captures medication reconciliation and discharge planning decisions relevant to patients for whom antiplatelet therapy might otherwise be considered, such as those with recent cardiovascular events or procedures. Nationally, accurate capture of discharge medication status supports care transitions, quality measurement, and population-level monitoring of adherence to evidence-based secondary prevention where applicable.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on the clinical meaning of the code, where it is typically applied (inpatient hospital or facility discharge), and how it is used in administrative reporting. The publication outlines common benchmarking topics and policy considerations related to discharge medication documentation, offers clinical context for when antiplatelet therapy is usually indicated, and highlights areas where coding completeness affects quality measurement. Data not available in the input is noted for specific fields where payor-specific policies, modifiers, taxonomies, ICD-10 pairings, and related codes would normally be listed.
Billing Code Overview
HCPCS Level II code G8581 indicates No antiplatelet medication at discharge. This code documents the discharge status of a patient who is not prescribed antiplatelet therapy at the time of hospital or facility discharge.
-
Service type: Medication reconciliation / discharge medication documentation
-
Typical site of service: Inpatient hospital or facility discharge setting
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult hospitalized for acute coronary syndrome (ACS) or after percutaneous coronary intervention (PCI) who, at discharge, is documented as not receiving any antiplatelet medication. The clinical workflow begins with inpatient cardiology evaluation and medication reconciliation prior to discharge. The treating team documents the clinical rationale for withholding antiplatelet therapy (for example, high bleeding risk, planned surgery, documented allergy, or patient refusal). Discharge orders, the medication administration record, and the discharge summary are reconciled by nursing and pharmacy to confirm no antiplatelet agent (such as aspirin, clopidogrel, prasugrel, or ticagrelor) is prescribed. The discharge documentation, including the problem list and instructions, reflects the absence of antiplatelet therapy and the reason for omission is clearly recorded for outpatient follow-up and care coordination.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
24 | Unrelated Evaluation and Management Service by the Same Physician During a Postoperative Period | Use if an unrelated E/M is provided while the patient is in a postoperative period and antiplatelet omission is documented during that E/M. |
25 |